About Solis Pharmachem Private Limited
Data last updated:
Solis Pharmachem Private Limited was a private limited company based in Ankleshwar, Gujarat, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 03 December 2019.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2019PTC111161.
The company had an authorised share capital of ₹25 Cr and a paid-up capital of ₹24.76 Cr. It was led by directors including Anil Kumar Jain and Samir Dhaga.
Its last annual general meeting (AGM) was held on 02 August 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Plot No. 4707/A/5 Sentogen Plot Near Lyka Chokdi, Ankleshwar, Gujarat, India – 393002.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.25 Cr. For the same year it recorded a net profit of ₹11.09 Lakh (net margin 2.6%) and EBITDA of ₹1.2 Cr (EBITDA margin 28.3%).
The company had about 26 employees on its provident fund (EPFO) records before it was dissolved.
The company has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹24.75 Cr; the latest was in April 2023. Its 5 peer companies in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 1 smaller; the largest is Sultaniya Sons Tradelink Private Limited with revenue of ₹4.27 Cr.
The last known website on record is solispharma.in.
Company details
Contact details
Solis Pharmachem Private Limited's registered office is in Ankleshwar, Gujarat. Its website is solispharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 4707/A/5 Sentogen Plot Near Lyka Chokdi, Ankleshwar, Gujarat, India – 393002
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Solis Pharmachem Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Solis Pharmachem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Solis Pharmachem Private Limited, buy the company report.
Financials of Solis Pharmachem Private Limited
FY 2023 filings availableSolis Pharmachem Private Limited reported revenue of ₹4.25 Cr for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.2 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹11.09 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 28.3% | |||
| Net Profit Margin | 2.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Solis Pharmachem Private Limited, buy the company report.
Board of directors of Solis Pharmachem Private Limited
Solis Pharmachem has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Jain | Director | 02 Jun 2023 | 3 Years 4 Months | As last reported |
| Samir Dhaga | Director | 02 Jun 2023 | 3 Years 4 Months | As last reported |
| Rajnish Sarna Also directs: Pi Industries Limited, Pi Fermachem Private Limited, Pi Bioferma Private Limited and 5 more | Director | 02 Jun 2023 | 3 Years 4 Months | As last reported |
Peer comparison
Solis Pharmachem Private Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sultaniya Sons Tradelink Private Limited | ₹4.27 Cr (FY 2025) | 12.0% | Jaipur, Rajasthan, India | |||
| Savvy Spechems Private Limited | ₹4.27 Cr (FY 2024) | 208.0% | Hyderabad, Telangana, India | |||
| Stas Biochem Private Limited | ₹4.26 Cr (FY 2025) | 35.0% | New Delhi, Delhi, India | |||
| Lunar Chemicals Private Limited | ₹4.26 Cr (FY 2025) | -25.0% | Kanpur, Uttar Pradesh, India | |||
| Solis Pharmachem Private Limitedthis company | ₹4.25 Cr (FY 2023) | ₹11.09 Lakh | 2.6% | 26 | Ankleshwar, Gujarat, India | |
| Matrix Filler Private Limited | ₹4.23 Cr (FY 2024) | 18336.0% | Gondal, Gujarat, India |
To see the full peer comparison of Solis Pharmachem Private Limited, buy the company report.
Auditor
Solis Pharmachem Private Limited is audited by Mathur Manish & Co for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mathur Manish & Co | FY 2022 | 0008162C |
Shareholding
The shareholding of Solis Pharmachem Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Solis Pharmachem Private Limited, buy the company report.
Deals & funding
Solis Pharmachem Private Limited has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹24.75 Cr; the latest was in April 2023.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2023 | Acquisition | ₹24.54 Cr | Buyer: Pi Health Sciences Limited |
| Nov 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2022 | Funding round | ₹1.98 Cr | Investors: Therachem Research Mediable LLC |
| Nov 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Solis Pharmachem Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Solis Pharmachem Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Solis Pharmachem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Solis Pharmachem Private Limited has a workforce of 26 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
No GST registration is on our record for Solis Pharmachem Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Solis Pharmachem Private Limited has 11 board changes on record since 2020: 3 appointments and 8 cessations. The latest: Anil Kumar Jain ceased to be Additional Director on 01 Aug 2023.
2 earlier events are in the company report.
Frequently asked questions
Solis Pharmachem has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Solis Pharmachem was a private limited company based in Ankleshwar, Gujarat, India. The company worked in industrial chemicals, within the chemicals and materials industry. It was incorporated on 03 December 2019 and is registered under CIN U24100GJ2019PTC111161. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Solis Pharmachem was incorporated on 03 December 2019. It is registered with the Registrar of Companies, Ahmedabad.
Solis Pharmachem had 3 directors:
- Anil Kumar Jain - Director
- Samir Dhaga - Director
- Rajnish Sarna - Director
The CIN (Corporate Identification Number) of Solis Pharmachem is U24100GJ2019PTC111161. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Solis Pharmachem is at Plot No. 4707A5 Sentogen Plot Near Lyka Chokdi, Ankleshwar, Gujarat, India – 393002.
Solis Pharmachem can be reached through the website solispharma.in. Its registered office is in Ankleshwar, Gujarat, India.
The latest financial statements of Solis Pharmachem on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 02 August 2023. Year-wise statements from FY 2020 are in the company report.
Solis Pharmachem operated in the chemicals and materials industry, in the industrial chemicals segment.
Solis Pharmachem has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹24.75 Cr; the latest was in April 2023.
The peers of Solis Pharmachem by revenue are Sultaniya Sons Tradelink Private Limited, Savvy Spechems Private Limited, Stas Biochem Private Limited, Lunar Chemicals Private Limited, Matrix Filler Private Limited, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
